Alessandro Tubita
Florence, 50134, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Design and Synthesis of Bendamustine-Carbonic Anhydrase Inhibitors with Antiproliferative Effects in Clear Cell Renal Cell Carcinoma.
Journal: Journal of medicinal chemistry
Published: June 24, 2026
Metabolomics Plasma Biomarkers Associated with the HRD Phenotype in Ovarian Cancer.
Journal: Metabolites
Published: November 13, 2025
KRAS G12C inhibition enhances efficacy to conventional chemotherapy in KRAS-mutant NSCLC.
Journal: Frontiers in oncology
Published: June 26, 2025
Dual-Specificity Protein Phosphatases Targeting Extracellular Signal-Regulated Kinases: Friends or Foes in the Biology of Cancer?
Journal: International journal of molecular sciences
Published: June 11, 2025
Transcriptomic analysis on pancreatic adenocarcinoma patients uncovers KRAS-mediated PPAR pathway alteration.
Journal: Frontiers in oncology
Published: April 17, 2025
The MEK5/ERK5 pathway promotes the activation of the Hedgehog/GLI signaling in melanoma cells.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: February 20, 2025
Liquid Crystalline Networks Hamper the Malignancy of Cancer Cells.
Journal: Advanced healthcare materials
Published: September 20, 2024
Importin subunit beta-1 mediates ERK5 nuclear translocation, and its inhibition synergizes with ERK5 kinase inhibitors in reducing cancer cell proliferation.
Journal: Molecular oncology
Published: October 03, 2023
Latent-Transforming Growth Factor β-Binding Protein 1/Transforming Growth Factor β1 Complex Drives Antitumoral Effects upon ERK5 Targeting in Melanoma.
Journal: The American journal of pathology
Published: September 15, 2023
Pathophysiological Impact of the MEK5/ERK5 Pathway in Oxidative Stress.
Journal: Cells
Published: January 11, 2023
Last Updated: 09/26/2026